OCTAGON ANNOUNCES UNPRECEDENTED GROWTH REFLECTED IN 2004 REVENUE
KING OF PRUSSIA, PA - February 1, 2005 - Octagon Research Solutions, the leader in the electronic transformation of clinical R&D, today announced that the organization's 2004 annual revenue represented an increase of over eighty percent (>80%) over 2003 revenues. The 2004 revenue number exceeded yearly forecasts and represents the combined revenues from four lines of business including Regulatory, Clinical, Process and IT Solutions. A key milestone from the past year contributing to this number was the company's first sale of ViewPoint®, a submission process management solution, to a top ten pharmaceutical organization.
James Walker, president and CEO of Octagon Research Solutions noted, "We have witnessed exceptional demand for our regulatory, process and clinical services while simultaneously launching an innovative process-focused software product. We have spent a significant amount of time and energy evaluating the industry landscape and developing offerings that provide the depth of expertise that our clients have come to expect. Our unparalleled success last year suggests that our process approach to clinical R&D is on target."
Octagon currently employs over one hundred and fifty (150) full-time employees including the largest pool of electronic publishing and eCTD (electronic Common Technical Document) professionals currently available in industry.
About Octagon Research Solutions, Inc.
Octagon is a leading process-centric solutions provider that offers a suite of regulatory, clinical, process and IT solutions to the life sciences industry. Octagon synchronizes processes and increases automation to reduce island-to-island inefficiencies within the clinical research and development process. We leverage the power of electronic submissions through cross-functional eSub expertise, a holistic process approach, deep domain knowledge and creative use of technology. Octagon is headquartered in King of Prussia, PA, with an office in Boston, MA. For more information please visit www.octagonresearch.com.
|